Recombinant Human AQP1 Protein，His

AQP1 (Aquaporin 1) is a member of the aquaporin family of transmembrane water channel proteins, initially discovered in the early 1990s. It is primarily expressed in the kidneys, eyes, and blood-brain barrier, playing a crucial role in regulating water homeostasis by facilitating the transport of water molecules across cell membranes. Due to its integral function in physiological processes such as urine concentration, lens transparency, and brain fluid homeostasis, AQP1 has garnered significant interest in various fields, including physiology, medicine, and biotechnology. Research on recombinant AQP1 protein is aimed at elucidating its structure-function relationships, understanding its role in diseases such as edema, glaucoma, and cancer, and exploring its potential as a therapeutic target. The production of AQP1 as a recombinant protein allows for detailed biochemical characterization, functional assays, and structure determination, enabling researchers to investigate how specific mutations or modifications could affect its activity. Additionally, recombinant AQP1 is utilized in drug delivery systems and bioengineering applications, highlighting its importance in both basic and applied research. The ongoing exploration of AQP1 not only enhances our knowledge of cellular water transport mechanisms but also opens up new avenues for developing therapies targeting water balance disorders.